Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Brain Res ; 1228: 107-12, 2008 Sep 04.
Article in English | MEDLINE | ID: mdl-18619422

ABSTRACT

Corticotropin-releasing hormone (CRH) is one of the anorexigenic neuropeptides, and indeed the expression of hypothalamic CRH is known to be inhibited by starvation. To clarify whether elevated plasma glucocorticoid during starvation is responsible for the CRH suppression, we examined the expression level of hypothalamic CRH mRNA after food deprivation in adrenalectomized, plasma corticosterone (B)-clamped animals. Male Wistar rats were divided into 2 groups: one group had adrenalectomy (ADX) and B pellet implantation (ADX+B, n=42), and the other group had only sham operation (sham, n=42). Rats were then treated with either ad libitum food supply or food deprivation for up to 96 h. The expression of CRH mRNA in the paraventricular nucleus (PVN) was estimated by in situ hybridization. After food deprivation, mean plasma B level was markedly elevated in sham group, but almost clamped in the ADX+B group. In this experimental condition, CRH mRNA in the PVN was significantly decreased in the sham group, whereas no change was obtained in the ADX+B group. Our data suggest the decrease in CRH mRNA seems to be related to the elevated glucocorticoid level during starvation. The status of hyperadrenocorticism without activation of CRH led us to speculate that adrenocortical function is predominant in the hypothalamic-pituitary-adrenal (HPA) axis during starvation.


Subject(s)
Corticotropin-Releasing Hormone/genetics , Hypothalamo-Hypophyseal System/physiology , Paraventricular Hypothalamic Nucleus/metabolism , Pituitary-Adrenal System/physiology , Starvation/physiopathology , Adrenalectomy/methods , Adrenocorticotropic Hormone/blood , Animals , Corticosterone/administration & dosage , Corticosterone/blood , Corticosterone/pharmacology , Corticotropin-Releasing Hormone/metabolism , Gene Expression/drug effects , Glucose/analysis , Hypothalamo-Hypophyseal System/drug effects , Hypothalamo-Hypophyseal System/metabolism , Hypothalamus/cytology , Hypothalamus/metabolism , Immunoradiometric Assay/methods , In Situ Hybridization , Injections, Subcutaneous , Insulin/blood , Male , Paraventricular Hypothalamic Nucleus/cytology , Paraventricular Hypothalamic Nucleus/drug effects , Pituitary-Adrenal System/drug effects , Pituitary-Adrenal System/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats , Rats, Wistar
2.
Curr Protein Pept Sci ; 7(3): 229-39, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16787262

ABSTRACT

Corticotropin-releasing factor (CRF), CRF-related peptides and their receptors are present in the central nervous system and in peripheral tissues including the immune, reproductive and cardiovascular systems. CRF and urocortin (urocortin 1) bind to the CRF receptor type 1 (CRF(1) receptor) and the CRF receptor type 2 (CRF(2) receptor), whereas urocortin 2 (formerly known as stresscopin related peptide) and urocortin 3 (formerly known as stresscopin) bind with high affinity to the CRF(2) receptor. Recent studies show that urocortin 1, urocortin 2 and urocortin 3 are potent regulators of cardiovascular function. This review highlights the role of cardiovascular CRF and related peptides and its relevance in mediating the adaptive response of the cardiovascular system to stressful conditions.


Subject(s)
Cardiovascular Physiological Phenomena , Corticotropin-Releasing Hormone/physiology , Receptors, Corticotropin-Releasing Hormone/physiology , Animals , Cardiovascular System/metabolism , Corticotropin-Releasing Hormone/metabolism , Corticotropin-Releasing Hormone/pharmacology , Glucocorticoids/metabolism , Humans , Peptide Hormones/metabolism , Peptide Hormones/pharmacology , Receptors, Corticotropin-Releasing Hormone/metabolism
3.
Brain Res ; 1048(1-2): 131-7, 2005 Jun 28.
Article in English | MEDLINE | ID: mdl-15919058

ABSTRACT

Previous studies have demonstrated that various types of stress increase type 1 corticotropin-releasing hormone (CRH) receptor (currently abbreviated to CRF1 receptor) mRNA in the hypothalamic paraventricular nucleus (PVN) of rats, but not mice. This study investigated whether different sensitivities of glucocorticoid-mediated negative feedback effects can explain this species difference in stress-induced PVN CRF1 receptor mRNA expression. First, the CRF1 receptor mRNA level in the PVN of CRH knockout (KO) mice during acute restraint stress was compared with that in wild-type (WT) mice. Consistent with previous findings, WT mice showed no induction of CRF1 receptor mRNA in the PVN following acute restraint, regardless of normal hypothalamic-pituitary-adrenocortical responses. In contrast, CRF1 receptor mRNA in the PVN of CRH KO mice was increased following 2 h of restraint. Since the response of tyrosine hydroxylase (TH) mRNA in the locus coeruleus (LC) to restraint was similar between CRH KO and WT mice, it is unlikely that enhanced noradrenergic input into the PVN was responsible for the CRF1 receptor mRNA induction in CRH KO mice. Second, to determine whether CRH KO per se or a low corticosterone response to stress is required to induce CRF1 receptor mRNA expression in the PVN in mice, the response of adrenalectomized WT mice was examined. Acute restraint increased the CRF1 receptor mRNA level in the PVN of adrenalectomized WT mice, similar to the case for CRH KO mice. TH mRNA in the LC showed similar increases in sham and adrenalectomized WT mice. These results indicate that PVN CRF1 receptor mRNA is much more sensitive to glucocorticoid-mediated negative feedback in mice than in rats, such that a normal increase in plasma corticosterone during stress can mask CRF1 receptor mRNA induction in the PVN of mice.


Subject(s)
Corticotropin-Releasing Hormone/deficiency , Paraventricular Hypothalamic Nucleus/metabolism , Receptors, Corticotropin-Releasing Hormone/metabolism , Restraint, Physical/methods , Stress, Physiological/metabolism , Adrenalectomy/methods , Animals , Corticosterone/blood , Corticotropin-Releasing Hormone/genetics , Gene Expression Regulation/physiology , In Situ Hybridization/methods , Mice , Mice, Knockout , RNA, Messenger/metabolism , Receptors, Corticotropin-Releasing Hormone/genetics
4.
Life Sci ; 72(10): 1159-69, 2003 Jan 24.
Article in English | MEDLINE | ID: mdl-12505546

ABSTRACT

We examined the effects of bisphenol A (0.5 microg/ml or 50 microg/ml) in the drinking water on estrogen receptor (ER) alpha and beta proteins and mRNA in the testis of young mice following 8-weeks of oral administration of bisphenol A utilizing immunohistochemistry and semiquantitative reverse transcription polymerase chain reaction amplification (RT-PCR). ER beta was clearly localized in the nuclei of spermatogonia and/or spermatocytes. ER beta immunopositive cell numbers per testis section were significantly decreased in the 50 microg/ml bisphenol A-treated group compared with control and the 0.5 microg/ml bisphenol A-treated group. The number of ER alpha positive cells in the testis was significantly lower than ER beta positive cells in control group. ER alpha immunopositive cell numbers per testis section were markedly increased in the 50 microg/ml bisphenol A-treated group compared with the control and the 0.5 microg/ml bisphenol A-treated group. ER beta mRNA expression was significantly decreased in the 50 microg/ml bisphenol A-treated group compared with the control and the 0.5 microg/ml bisphenol A-treated group. In contrast, ER alpha mRNA expression was markedly increased in the 50 microg/ml bisphenol A-treated group compared with the control and the 0.5 microg/ml bisphenol A-treated group. The existence of ER alpha and beta in the testis suggests that estrogens directly affect germ cells during testicular development and spermatogenesis, and differential modulation of ER alpha and beta in the testis could be involved in the effects of bisphenol A.


Subject(s)
Estrogens, Non-Steroidal/pharmacology , Phenols/pharmacology , RNA, Messenger/biosynthesis , Receptors, Estrogen/drug effects , Testis/metabolism , Animals , Benzhydryl Compounds , Body Weight/drug effects , DNA, Complementary/biosynthesis , Estrogen Receptor alpha , Estrogen Receptor beta , Immunohistochemistry , Male , Mice , Mice, Inbred C57BL , Organ Size/drug effects , Reverse Transcriptase Polymerase Chain Reaction , Spleen/drug effects , Testis/cytology , Testis/drug effects
5.
Regul Pept ; 105(2): 121-9, 2002 May 15.
Article in English | MEDLINE | ID: mdl-11891012

ABSTRACT

The present study was conducted to assess the effect of nutritional stress induced by food deprivation on expression of messenger ribonucleic acid (mRNA) for corticotropin-releasing hormone receptor type 2beta (CRH-R2beta) in the rat cardiovascular system in the presence or absence of changes in circulating corticosterone. Food deprivation for 96 h caused a robust increase in plasma corticosterone levels and a significant decrease in CRH-R2beta mRNA expression in the rat heart. Starvation for 48 and 96 h decreased CRH-R2beta mRNA expression in the atria, ventricle as well as aorta of sham-adrenalectomized (sham) rats. Surprisingly, clamping plasma glucocorticoids at low levels by adrenalectomy with corticosterone pellet replacement (ADX+B) did not completely prevent starvation-induced decreases of CRH-R2beta mRNA expression in the rat cardiovascular system. Urocortin (Ucn) mRNA expression was increased significantly by food deprivation in the heart of sham as well as ADX+B rats. We speculate that food deprivation may increase urocortin, which in turn down-regulates CRH-R2beta mRNA expression in cardiovascular system. These data indicate that food deprivation despite the presence or absence of changes in circulating corticosterone may have an inhibitory effect on CRH-R2beta mRNA expression in the rat cardiovascular system.


Subject(s)
Down-Regulation , Fasting/metabolism , Myocardium/metabolism , Receptors, Corticotropin-Releasing Hormone/genetics , Adrenal Glands/metabolism , Adrenalectomy , Animals , Body Weight , Cardiovascular System/metabolism , Corticosterone/blood , Corticotropin-Releasing Hormone/genetics , Food Deprivation , Male , Organ Size , RNA, Messenger/metabolism , Rats , Rats, Wistar , Thymus Gland , Urocortins
SELECTION OF CITATIONS
SEARCH DETAIL
...